Fusen Pharma Shareholders Unanimously Approve RMB300 Million Capital Injection into Henan Subsidiary

Bulletin Express

Jul 09

Fusen Pharmaceutical Company Limited (Fusen Pharma) confirmed that shareholders at the 9 July 2026 Extraordinary General Meeting (EGM) approved the Capital Increase Agreement, paving the way for a RMB300.00 million injection into its wholly owned subsidiary, Henan Fusen Pharmaceutical Company Limited.

The funding will be provided by two external investors—Nanyang Industrial Investment Health Industry Group Co., Ltd. and Henan Xisheng Industrial Development Co., Ltd.—pursuant to an agreement signed on 18 June 2026. The new funds will be subscribed as additional registered capital of the target company.

Voting snapshot • Votes in favour: 334.88 million (100.00%) • Votes against: 0 (0.00%) • Total votes cast: 334.88 million, representing 45.30 % of Fusen Pharma’s 739.30 million issued shares

With more than 50 % of votes cast in favour, the resolution passed as an ordinary resolution. All directors attended the meeting, and Computershare Hong Kong Investor Services Limited acted as the independent scrutineer for vote counting.

Following shareholder approval, Fusen Pharma’s board is authorised to execute all necessary documents and actions to finalise the capital increase and related transactions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/news/1141818063"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1141818063\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1141818063?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-09 17:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141818063","market":"us","top_or_hot":-1,"title":"Fusen Pharma Shareholders Unanimously Approve RMB300 Million Capital Injection into Henan Subsidiary","media":"Bulletin Express","content":"<p>Fusen Pharmaceutical Company Limited (Fusen Pharma) confirmed that shareholders at the 9 July 2026 Extraordinary General Meeting (EGM) approved the Capital Increase Agreement, paving the way for a RMB300.00 million injection into its wholly owned subsidiary, Henan Fusen Pharmaceutical Company Limited.</p>\n<p>The funding will be provided by two external investors—Nanyang Industrial Investment Health Industry Group Co., Ltd. and Henan Xisheng Industrial Development Co., Ltd.—pursuant to an agreement signed on 18 June 2026. The new funds will be subscribed as additional registered capital of the target company.</p>\n<p>Voting snapshot  \n• Votes in favour: 334.88 million (100.00%)  \n• Votes against: 0 (0.00%)  \n• Total votes cast: 334.88 million, representing 45.30 % of Fusen Pharma’s 739.30 million issued shares</p>\n<p>With more than 50 % of votes cast in favour, the resolution passed as an ordinary resolution. All directors attended the meeting, and Computershare Hong Kong Investor Services Limited acted as the independent scrutineer for vote counting.</p>\n<p>Following shareholder approval, Fusen Pharma’s board is authorised to execute all necessary documents and actions to finalise the capital increase and related transactions.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fusen Pharma Shareholders Unanimously Approve RMB300 Million Capital Injection into Henan Subsidiary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFusen Pharma Shareholders Unanimously Approve RMB300 Million Capital Injection into Henan Subsidiary\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-09 17:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Fusen Pharmaceutical Company Limited (Fusen Pharma) confirmed that shareholders at the 9 July 2026 Extraordinary General Meeting (EGM) approved the Capital Increase Agreement, paving the way for a RMB300.00 million injection into its wholly owned subsidiary, Henan Fusen Pharmaceutical Company Limited.</p>\n<p>The funding will be provided by two external investors—Nanyang Industrial Investment Health Industry Group Co., Ltd. and Henan Xisheng Industrial Development Co., Ltd.—pursuant to an agreement signed on 18 June 2026. The new funds will be subscribed as additional registered capital of the target company.</p>\n<p>Voting snapshot  \n• Votes in favour: 334.88 million (100.00%)  \n• Votes against: 0 (0.00%)  \n• Total votes cast: 334.88 million, representing 45.30 % of Fusen Pharma’s 739.30 million issued shares</p>\n<p>With more than 50 % of votes cast in favour, the resolution passed as an ordinary resolution. All directors attended the meeting, and Computershare Hong Kong Investor Services Limited acted as the independent scrutineer for vote counting.</p>\n<p>Following shareholder approval, Fusen Pharma’s board is authorised to execute all necessary documents and actions to finalise the capital increase and related transactions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01652","symbol_name":"福森药业","start_time":0,"source_url":"","article_id":"1141818063","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141818063","pubTimestamp":1783587890,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Fusen Pharmaceutical Company Limited (Fusen Pharma) confirmed that shareholders at the 9 July 2026 Extraordinary General Meeting (EGM) approved the Capital Increase Agreement, paving the way for a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01652":"福森药业"},"translate_title":"福森药业股东一致批准向河南子公司注资3亿元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01652":1},"content_text":"Fusen Pharmaceutical Company Limited (Fusen Pharma) confirmed that shareholders at the 9 July 2026 Extraordinary General Meeting (EGM) approved the Capital Increase Agreement, paving the way for a RMB300.00 million injection into its wholly owned subsidiary, Henan Fusen Pharmaceutical Company Limited.\nThe funding will be provided by two external investors—Nanyang Industrial Investment Health Industry Group Co., Ltd. and Henan Xisheng Industrial Development Co., Ltd.—pursuant to an agreement signed on 18 June 2026. The new funds will be subscribed as additional registered capital of the target company.\nVoting snapshot  \n• Votes in favour: 334.88 million (100.00%)  \n• Votes against: 0 (0.00%)  \n• Total votes cast: 334.88 million, representing 45.30 % of Fusen Pharma’s 739.30 million issued shares\nWith more than 50 % of votes cast in favour, the resolution passed as an ordinary resolution. All directors attended the meeting, and Computershare Hong Kong Investor Services Limited acted as the independent scrutineer for vote counting.\nFollowing shareholder approval, Fusen Pharma’s board is authorised to execute all necessary documents and actions to finalise the capital increase and related transactions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}